a b s t r a c t
With the population aging and a dramatic increase in the number of senior citizens, public health systems will be increasingly burdened with the need to deal with the care and treatment of individuals with dementia. We review evidence demonstrating how a particular experience, bilingualism, has been shown to protect cognitive function in older age and delay onset of symptoms of dementia. This paper describes behavioral and brain studies that have compared monolingual and bilingual older adults on measures of cognitive function or brain structure and reviews evidence demonstrating a protective effect of bilingualism against symptoms of dementia. We conclude by presenting some data showing the potential savings in both human costs in terms of demented patients and economic considerations in terms of public money if symptoms of dementia could be postponed.
© 2016 Elsevier B.V. All rights reserved. The decline of cognitive function with adult aging and the risk of experiencing clinical impairment in the form of mild cognitive impairment (MCI) or Alzheimer's disease (AD) make understanding the process of cognitive decline and the search for remediation an urgent priority. The high prevalence of dementia (Graham et al., 1997; Plassman et al., 2007) in conjunction with the explosive growth in the number of senior citizens present enormous challenges to national economies and the management of health care. Any progress in rethinking the causes of cognitive decline and the creation of novel approaches to intervention would make a significant contribution to public health. This research, however, has been dominated by biological models with insufficient regard for environmental and experiential factors. A more balanced view is needed for progress on these crucial issues.
Contents
There have been advances in understanding the biological basis of AD (Weiner et al., 2012) and developing pharmacological therapies (Zhu et al., 2013) , but the effectiveness of these approaches remains limited. Massoud and Gauthier (2010) claim that the benefits of existing drugs for symptomatic treatments in dementia are modest, and some argue that the magnitude of this benefit, although statistically significant, is marginal at best and difficult to detect, measure, and quantify clinically (Hildreth and Church, 2015; Kaduszkiewicz et al., 2005; Raina et al., 2008 ). Yet, enabling people to function independently for longer has immediate social and economic benefit by adding quality of life to the patient and time during which health care resources are not required. Importantly, some environmental factors have been shown to maintain cognitive functioning with aging and postpone the onset of symptoms of dementia. These factors contribute to a concept called 'cognitive http://dx.doi.org/10.1016/j.arr.2016.03.003 1568-1637/© 2016 Elsevier B.V. All rights reserved.
